IN2015DN01547A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01547A IN2015DN01547A IN1547DEN2015A IN2015DN01547A IN 2015DN01547 A IN2015DN01547 A IN 2015DN01547A IN 1547DEN2015 A IN1547DEN2015 A IN 1547DEN2015A IN 2015DN01547 A IN2015DN01547 A IN 2015DN01547A
- Authority
- IN
- India
- Prior art keywords
- compounds
- methods
- compositions
- variables
- articles
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 abstract 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940100243 oleanolic acid Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
- Steroid Compounds (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261699199P | 2012-09-10 | 2012-09-10 | |
PCT/US2013/059015 WO2014040056A1 (fr) | 2012-09-10 | 2013-09-10 | Dérivés c17-hétéroarylés de l'acide oléanolique et leurs procédés d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN01547A true IN2015DN01547A (fr) | 2015-07-03 |
Family
ID=49253401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1547DEN2015 IN2015DN01547A (fr) | 2012-09-10 | 2013-09-10 |
Country Status (28)
Country | Link |
---|---|
US (1) | US20140088163A1 (fr) |
EP (1) | EP2892911B1 (fr) |
JP (1) | JP6272870B2 (fr) |
KR (1) | KR102237364B1 (fr) |
CN (1) | CN104768965B (fr) |
AU (1) | AU2013312102B2 (fr) |
BR (1) | BR112015005200B1 (fr) |
CA (1) | CA2882417C (fr) |
CY (1) | CY1119762T1 (fr) |
DK (1) | DK2892911T3 (fr) |
EA (1) | EA029069B1 (fr) |
ES (1) | ES2644615T3 (fr) |
HK (1) | HK1211295A1 (fr) |
HR (1) | HRP20171565T1 (fr) |
HU (1) | HUE036797T2 (fr) |
IL (1) | IL237638B (fr) |
IN (1) | IN2015DN01547A (fr) |
LT (1) | LT2892911T (fr) |
ME (1) | ME02911B (fr) |
MX (1) | MX366954B (fr) |
NZ (1) | NZ705213A (fr) |
PL (1) | PL2892911T3 (fr) |
PT (1) | PT2892911T (fr) |
RS (1) | RS56563B1 (fr) |
SG (1) | SG11201501800UA (fr) |
SI (1) | SI2892911T1 (fr) |
WO (1) | WO2014040056A1 (fr) |
ZA (1) | ZA201501203B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4923146B2 (ja) | 2008-01-11 | 2012-04-25 | リアタ ファーマシューティカルズ インコーポレイテッド | 合成トリテルペノイドおよび疾患の治療における使用方法 |
ES2703274T3 (es) | 2008-04-18 | 2019-03-07 | Reata Pharmaceuticals Inc | Moduladores de la inflamación antioxidantes: derivados del ácido oleanólico con modificaciones amino y otras en C-17 |
JP5564490B2 (ja) | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗炎症性ファルマコアを含む化合物および使用法 |
LT2651902T (lt) | 2010-12-17 | 2018-01-10 | Reata Pharmaceuticals, Inc. | Tricikliniai pirazolil- ir pirimidinilenonai, kaip antioksidantų uždegimo moduliatoriai |
TWI623548B (zh) | 2012-04-27 | 2018-05-11 | 瑞塔醫藥有限責任公司 | 齊墩果酸(bardoxolone methyl)之2,2-二氟基丙醯胺衍生物、多晶型及其使用方法 |
US9556222B2 (en) | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
MY180903A (en) | 2012-09-10 | 2020-12-11 | Reata Pharmaceuticals Inc | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
AR096046A1 (es) | 2013-04-24 | 2015-12-02 | Abbvie Inc | Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso |
CN107428698B (zh) | 2015-02-12 | 2021-10-26 | 里亚塔医药公司 | 作为抗氧化炎症调节剂的咪唑基三环烯酮 |
CN108290922B (zh) | 2015-09-23 | 2021-12-07 | 里亚塔医药公司 | 用于抑制il-17和其它用途的c4-改性的齐墩果酸衍生物 |
US10953020B2 (en) | 2016-11-08 | 2021-03-23 | Reata Pharmaceuticals, Inc. | Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof |
CN106632574B (zh) * | 2016-12-07 | 2018-05-29 | 广东天键生物科技有限公司 | 一种化合物、其制备方法及用途 |
TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物 |
CN111417384A (zh) | 2017-09-14 | 2020-07-14 | 菲尼克斯生物技术公司 | 用于治疗神经系统病况的方法和改进的神经保护性组合物 |
CA3075729A1 (fr) | 2017-09-14 | 2019-03-21 | Phoenix Biotechnology, Inc. | Utilisation d'oleandrine pour traiter une infection virale |
CA3103726A1 (fr) | 2018-06-15 | 2019-12-19 | Reata Pharmaceuticals, Inc. | Composes pyrazole et imidazole pour l'inhibition de l'il-17 et du rorgamma |
JP2022501445A (ja) * | 2018-09-28 | 2022-01-06 | スーチョワン ハイスコ ファーマスーティカル カンパニー リミテッドSichuan Haisco Pharmaceutical Co., Ltd. | テルペノイド誘導体及びその用途 |
KR20220044942A (ko) * | 2019-07-19 | 2022-04-12 | 리아타 파마슈티컬즈, 아이엔씨. | C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법 |
WO2021201903A1 (fr) | 2020-03-31 | 2021-10-07 | Phoenix Biotechnology, Inc. | Méthode et compositions pour le traitement d'une infection à coronavirus |
EP4295854A3 (fr) | 2020-03-31 | 2024-04-03 | Phoenix Biotechnology, Inc. | Méthode et compositions pour le traitement d'une infection à coronavirus |
JP7214696B2 (ja) * | 2020-10-01 | 2023-01-30 | 一般財団法人 化学物質評価研究機構 | 新規in vitro皮膚感作性試験法 |
WO2022126129A1 (fr) | 2020-12-11 | 2022-06-16 | Reata Pharmaceuticals, Inc. | Triterpénoïdes synthétiques destinés à être utilisés en thérapie |
AU2022208727A1 (en) | 2021-01-18 | 2023-08-03 | Reata Pharmaceuticals, Inc. | Synthetic ursolic acid derivatives and methods of use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
EP1507541A4 (fr) * | 2002-05-13 | 2009-06-03 | Dartmouth College | Inhibiteurs et procedes d'utilisation de ceux-ci |
JP4923146B2 (ja) | 2008-01-11 | 2012-04-25 | リアタ ファーマシューティカルズ インコーポレイテッド | 合成トリテルペノイドおよび疾患の治療における使用方法 |
EP2271658B1 (fr) * | 2008-04-18 | 2016-11-09 | Reata Pharmaceuticals, Inc. | Modulateurs d'inflammation antioxydants : dérivés d'acide oléanolique c-17 homologués |
CN102164941B (zh) * | 2008-04-18 | 2015-05-27 | 里亚塔医药公司 | 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物 |
ES2703274T3 (es) | 2008-04-18 | 2019-03-07 | Reata Pharmaceuticals Inc | Moduladores de la inflamación antioxidantes: derivados del ácido oleanólico con modificaciones amino y otras en C-17 |
WO2009146216A2 (fr) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals. Inc. | Modulateurs d’inflammation antioxydant : nouveaux dérivés d’acide oléanolique |
ME03469B (fr) * | 2011-03-11 | 2020-01-20 | Reata Pharmaceuticals Inc | Dérivés monométhyle triterpénoïdes en c4 et leurs procédés d'utilisation |
US9556222B2 (en) * | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
-
2013
- 2013-09-10 DK DK13767175.6T patent/DK2892911T3/en active
- 2013-09-10 PT PT137671756T patent/PT2892911T/pt unknown
- 2013-09-10 US US14/022,843 patent/US20140088163A1/en not_active Abandoned
- 2013-09-10 KR KR1020157009160A patent/KR102237364B1/ko active IP Right Grant
- 2013-09-10 RS RS20171140A patent/RS56563B1/sr unknown
- 2013-09-10 CA CA2882417A patent/CA2882417C/fr active Active
- 2013-09-10 WO PCT/US2013/059015 patent/WO2014040056A1/fr active Application Filing
- 2013-09-10 ME MEP-2017-254A patent/ME02911B/fr unknown
- 2013-09-10 PL PL13767175T patent/PL2892911T3/pl unknown
- 2013-09-10 BR BR112015005200-2A patent/BR112015005200B1/pt active IP Right Grant
- 2013-09-10 CN CN201380057684.2A patent/CN104768965B/zh active Active
- 2013-09-10 AU AU2013312102A patent/AU2013312102B2/en active Active
- 2013-09-10 SG SG11201501800UA patent/SG11201501800UA/en unknown
- 2013-09-10 EA EA201590539A patent/EA029069B1/ru unknown
- 2013-09-10 ES ES13767175.6T patent/ES2644615T3/es active Active
- 2013-09-10 HU HUE13767175A patent/HUE036797T2/hu unknown
- 2013-09-10 JP JP2015531317A patent/JP6272870B2/ja active Active
- 2013-09-10 IN IN1547DEN2015 patent/IN2015DN01547A/en unknown
- 2013-09-10 NZ NZ705213A patent/NZ705213A/en unknown
- 2013-09-10 MX MX2015003078A patent/MX366954B/es active IP Right Grant
- 2013-09-10 EP EP13767175.6A patent/EP2892911B1/fr active Active
- 2013-09-10 LT LTEP13767175.6T patent/LT2892911T/lt unknown
- 2013-09-10 SI SI201330818T patent/SI2892911T1/sl unknown
-
2015
- 2015-02-23 ZA ZA2015/01203A patent/ZA201501203B/en unknown
- 2015-03-09 IL IL237638A patent/IL237638B/en active IP Right Grant
- 2015-12-07 HK HK15112022.0A patent/HK1211295A1/xx unknown
-
2017
- 2017-10-16 HR HRP20171565TT patent/HRP20171565T1/hr unknown
- 2017-11-03 CY CY20171101157T patent/CY1119762T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN01547A (fr) | ||
IN2015DN01442A (fr) | ||
MX348862B (es) | Derivados c4-monometil triterpenoides y sus metodos de uso. | |
WO2012083306A3 (fr) | Pyrazolyl- et pyrimidinyl-énones tricycliques en tant que modulateurs d'inflammation antioxydants | |
WO2009129545A8 (fr) | Modulateurs d'inflammation antioxydants: dérivés d'acide oléanolique présentant une saturation dans l'anneau c | |
PH12016501192B1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
UA110354C2 (uk) | Противірусні сполуки | |
MX2015013042A (es) | Compuestos organicos. | |
PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
MX350211B (es) | Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico. | |
MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
IN2014MN01469A (fr) | ||
IN2015DN00950A (fr) | ||
IN2014MN02393A (fr) | ||
AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
NZ705902A (en) | Isoxazolidine derivatives | |
MX348841B (es) | Derivados de pirimidooxazocina como inhibidores de mtor. | |
MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
CR20120109A (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
GEP20156247B (en) | Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them | |
IN2013MU02279A (fr) | ||
RS20150238A1 (en) | (S) -2-AMINO-3-CYCLOHEXYLPROPANIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |